Asked by: Apsana Begum (Labour - Poplar and Limehouse)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, whether the Health and Safety Executive pursued prosecution of (a) public and (b) private sector employers for failure to abide by health and safety legislation during the Covid 19 pandemic.
Answered by Paul Maynard - Parliamentary Under-Secretary (Department for Work and Pensions)
The Health and Safety at Work etc Act (HSWA) 1974 is the primary piece of legislation covering occupational health and safety in Great Britain. It sets out the general duties which employers have towards employees and members of the public, employees have to themselves and to each other and certain self-employed have towards themselves and others.
HSWA applies equally across all workplaces in all industry sectors and does not distinguish between either public or private sector duty-holders. As such, the Health and Safety Executive (HSE) would not routinely differentiate or record this information.
The prosecution data below is for the time period of the 1st April 2020 and the 31st March 2022, this being the timeframe of the pandemic prior to HSE returning to business as usual. The figures are for all prosecutions taken under health and safety legislation which were published in the HSE Annual Report 2020/21 and 2021/22 respectively and are not Covid specific.
HSE pursued 206 prosecutions in 2020/21, with a 94% conviction rate, and 290 prosecutions in 2021/22, with a 96% conviction rate. A total of 496 prosecutions across the period referred to.
Asked by: Apsana Begum (Labour - Poplar and Limehouse)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, whether the Health and Safety Executive is investigating (a) public and (b) private sector employers for failure to abide by health and safety legislation during the Covid 19 pandemic.
Answered by Paul Maynard - Parliamentary Under-Secretary (Department for Work and Pensions)
The Health and Safety at Work etc Act (HSWA) 1974 is the primary piece of legislation covering occupational health and safety in Great Britain. It sets out the general duties which employers have towards employees and members of the public, employees have to themselves and to each other and certain self-employed have towards themselves and others.
HSWA applies equally across all workplaces in all industry sectors and does not distinguish between either public or private sector duty-holders. As such, the Health and Safety Executive (HSE) would not routinely differentiate or record this information.
Asked by: Apsana Begum (Labour - Poplar and Limehouse)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, whether any (a) public and (b) private sector employer has been reported to the Health and Safety Executive for failure to abide by health and safety legislation during the Covid 19 pandemic.
Answered by Paul Maynard - Parliamentary Under-Secretary (Department for Work and Pensions)
The Health and Safety at Work etc Act (HSWA) 1974 is the primary piece of legislation covering occupational health and safety in Great Britain. It sets out the general duties which employers have towards employees and members of the public, employees have to themselves and to each other and certain self-employed have towards themselves and others.
HSWA applies equally across all workplaces in all industry sectors and does not distinguish between either public or private sector duty-holders. As such, the Health and Safety Executive (HSE) would not routinely differentiate or record this information.
Reports received by HSE are generally in the form of a ‘concern’. These can be in relation to any health and safety issue in the workplace and can be submitted via HSE’s online reporting portal.
Between the 1st April 2020 and the 31st March 2022, this being the timeframe of the pandemic prior to HSE returning to business as usual, HSE handled over 70,000 concerns about health and safety in the workplace.
However, not all of these concerns were in relation to a failure to abide by health and safety legislation, some were requests for general health and safety advice, support, and guidance. This data has been published in the HSE Annual Report 2020/21 and 2021/22 respectively and is not Covid specific.
Apr. 15 2024
Source Page: Request by an individual for information about a vehicle (form V888)Found: message about delays. 6 August 2020 Paper application info added in summary. 18 June 2020 Amended coronavirus
Correspondence Apr. 15 2024
Committee: Social Justice and Social Security CommitteeFound: Due to staff redeployments in the coronavirus pandemic, this work was put on hold.
Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her policies of the article in the British Medical Journal entitled Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds, published on 27 May 2021; and if she will have discussions with the Medicines and Healthcare products Regulatory Agency on the contents of the report.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Following the initial roll out of the COVID-19 vaccination programme in December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) had a comprehensive surveillance strategy in place, enabling continual close monitoring of emerging safety evidence including studies, published literature, and data arising from the widespread use in the United Kingdom and globally. This included the article and Norwegian reports highlighted. The MHRA communicates safety advice based upon consideration of the totality of evidence from all relevant information sources, rather than the strengths and limitations of individual data sources.
Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if the Medicines and Healthcare products Regulatory Agency will establish an expert review panel to investigate the cause of death for reports of suspected (i) fatal outcomes and (ii) adverse reactions in patients who have received a covid-19 vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Medicines and Healthcare products Regulatory Agency’s (MHRA) role is to ensure that the benefits associated with a medicinal product outweigh the known risks, at the time of first authorisation and thereafter. Whilst the MHRA seeks expert advice from the Commission on Human Medicines and its expert advisory groups on the likelihood of an association between a COVID-19 vaccine and a safety concern, this is based on the totality of evidence from Yellow Card data, and relevant information from other sources. Should a new link between a medicine and a safety concern be confirmed, the MHRA will take necessary regulatory action, such as updating product information to include a warning for patients and healthcare professionals.
Asked by: Neale Hanvey (Alba Party - Kirkcaldy and Cowdenbeath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many reports have been received by the Medicines and Healthcare products Regulatory Agency on (i) fatal outcomes and (ii) adverse reactions in patients who have received a covid-19 vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Medicines and Healthcare products Regulatory Agency has received 489,004 spontaneous suspected adverse drug reaction reports relating to a COVID-19 vaccine up to and including 28 February 2024, within the United Kingdom. 2,734 of the reports were associated with a fatal outcome. Reporters are asked to submit Yellow Card reports even if they only have a suspicion that the vaccine may have caused the adverse reaction. The existence of an adverse reaction report does not necessarily mean that the vaccine has caused the reaction. Reporting rates can be influenced by many factors, including the seriousness of the adverse reactions, their ease of recognition, and the extent of the use of a particular vaccine.